Elevated C-Reactive Protein Level Amplifies the Association of Lipoprotein(a) With Cardiovascular Risk and Risk Reduction With Alirocumab After Acute Coronary Syndrome

被引:0
|
作者
Schwartz, Gregory G.
Szarek, Michael
Bhatt, Deepak
Bittner, Vera A.
Diaz, Rafael
Garon, Genevive
Goodman, Shaun G.
Harrington, Robert A.
Jukema, J. Wouter W.
Manvelian, Garen
Pordy, Robert
White, Harvey D.
Zeiher, Andreas M.
Steg, Philippe G.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A10291
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention
    Yuan, Deshan
    Wang, Peizhi
    Jia, Sida
    Zhang, Ce
    Zhu, Pei
    Jiang, Lin
    Liu, Ru
    Xu, Jingjing
    Tang, Xiaofang
    Song, Ying
    Yao, Yi
    Xu, Na
    Zhang, Yin
    Zhao, Xueyan
    Yang, Yuejin
    Xu, Bo
    Gao, Lijian
    Gao, Zhan
    Gao, Runlin
    Yuan, Jinqing
    ATHEROSCLEROSIS, 2022, 363 : 109 - 116
  • [22] RELATION OF LIPOPROTEIN(A) AND ITS REDUCTION BY ALIROCUMAB WITH INSULIN, INSULIN RESISTANCE, AND RISK OF NEW ONSET DIABETES AFTER ACUTE CORONARY SYNDROME
    Schwartz', Gregory G.
    Szarek, Michael
    Jukema, Johan Wouter
    Cobbaert, Christa
    Reijnders, Esther
    Bittner, Vera
    Schwertfeger, Markus
    Bhatt, Deepak L.
    Fazio, Sergio
    Garon, Genevieve
    Goodman, Shaun G.
    White, Harvey D.
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1964 - 1964
  • [23] C-reactive protein in addition to GRACE Score improves risk stratification in acute coronary syndrome
    Devesa Neto, V.
    Fiuza, J.
    Correia, J.
    Ferreira, G.
    Marmelo, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 335 - 335
  • [24] C-reactive protein levels and cardiovascular risk after statin therapy
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (3): : 118 - 118
  • [25] C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS?
    Koenig, Wolfgang
    CLINICAL CHEMISTRY, 2017, 63 (12) : 1897 - 1898
  • [26] Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels
    Fichtlscherer, S
    Zeiher, AM
    ANNALS OF MEDICINE, 2000, 32 (08) : 515 - 518
  • [27] Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians
    Mahajan, Anubha
    Jaiswal, Alok
    Tabassum, Rubina
    Podder, Avijit
    Ghosh, Saurabh
    Madhu, S. V.
    Mathur, Sandeep K.
    Tandon, Nikhil
    Bharadwaj, Dwaipayan
    ATHEROSCLEROSIS, 2012, 220 (01) : 275 - 281
  • [28] Risk of cardiovascular disease in US persons with metabolic risk factors, diabetes, and elevated C-reactive protein
    Malik, S
    Wong, N
    Franklin, S
    Pio, J
    Chen, R
    Fairchild, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 486A - 486A
  • [29] Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies
    Yang, Xingjin
    Zhang, Dongdong
    Zhao, Yang
    Liu, Dechen
    Li, Quanman
    Guo, Chunmei
    Tian, Gang
    Han, Minghui
    Qie, Ranran
    Huang, Shengbing
    Zhou, Qionggui
    Zhao, Yang
    Feng, Yifei
    Wu, Xiaoyan
    Zhang, Yanyan
    Li, Yang
    Wu, Yuying
    Cheng, Cheng
    Hu, Dongsheng
    Sun, Liang
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (12) : 1149 - 1158
  • [30] Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies
    Xingjin Yang
    Dongdong Zhang
    Yang Zhao
    Dechen Liu
    Quanman Li
    Chunmei Guo
    Gang Tian
    Minghui Han
    Ranran Qie
    Shengbing Huang
    Qionggui Zhou
    Yang Zhao
    Yifei Feng
    Xiaoyan Wu
    Yanyan Zhang
    Yang Li
    Yuying Wu
    Cheng Cheng
    Dongsheng Hu
    Liang Sun
    Journal of Human Hypertension, 2021, 35 : 1149 - 1158